Status:

UNKNOWN

The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

Lead Sponsor:

Wonju Severance Christian Hospital

Conditions:

Heart Failure

Mortality

Eligibility:

All Genders

18+ years

Brief Summary

This study aimed to evaluate the effectiveness, safety, and cost-effectiveness of ARNI and ACEi/ARBs in real-world practice. This study could find out what the unmet medical needs are in real world pr...

Detailed Description

Despite developments and improvements in treatment strategies, heart failure (HF) remains a significant socioeconomic burden and leads to individual health problems due to its high mortality and readm...

Eligibility Criteria

Inclusion

  • HF patients were defined as those with "heart failure" according to the disease code in the main code and the sub-code in the claims data.
  • HF patients who were assigned the following KCD-6 disease codes were considered as: "hypertensive heart disease with (congestive) HF" (I11.0), "hypertensive heart and renal disease with (congestive) HF" (I13.0), "hypertensive heart and renal disease with both (congestive) HF and renal failure" (I13.2), and "HF" (I50) including "congestive HF" (I50.0), "LV failure" (I50.1), and "HF and unspecified" (I50.9).
  • HFrEF patients were defined with the following KCD-6 disease codes: "Congestive heart failure with systolic dysfunction"(I5004), "Left ventricular failure"(I501), "Ischaemic cardiomyopathy"(I22.5), "Dilated cardiomyopathy" (I420).
  • Hospitalized heart failure is defined as the HF disease code and admission.

Exclusion

  • Less than 18 years old
  • In case where investigators determine it's inappropriate to be included in the study as per investigators' clinical judgment

Key Trial Info

Start Date :

February 18 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

1000000 Patients enrolled

Trial Details

Trial ID

NCT05329727

Start Date

February 18 2022

End Date

December 31 2025

Last Update

August 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yonsei University Wonju College of Medicine

Wŏnju, Gangwondo, South Korea, 26426

The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF | DecenTrialz